Sermorelin GH Stimulation refers to the diagnostic or therapeutic use of Sermorelin, a synthetic GHRH analog, to provoke a measurable release of endogenous Growth Hormone (GH) from the anterior pituitary gland. This procedure is used clinically to assess the functional reserve of the somatotroph axis, particularly when baseline GH levels are low or questionable. It provides direct evidence of pituitary responsiveness to hypothalamic stimulation.
Origin
Sermorelin is a synthetic peptide mimicking the first 29 amino acids of native Growth Hormone-Releasing Hormone (GHRH). ‘GH Stimulation’ describes the intended physiological effect—provoking growth hormone secretion.
Mechanism
Sermorelin acts by binding specifically to the GHRH receptor located on the surface of pituitary somatotroph cells. This binding activates the adenylyl cyclase pathway, leading to an increase in intracellular cyclic AMP (cAMP). Elevated cAMP levels then initiate the cascade necessary for the synthesis and exocytosis of preformed GH stores, resulting in a measurable surge of GH into the systemic circulation. The magnitude of this surge reflects the health and functional capacity of the pituitary gland.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.